4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000129
Options or other derivatives
- SVP, Chief Scientific Officer acquired 153,846 shares (grant or award)
- SVP, Chief Scientific Officer returned 153,846 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/wf-form4_157377039293557.xml…